Cipla to invest on new projects, expansionIllustrative image – not actual.

Cipla has drawn up an investment plan for setting up factories, expansion of existing facilities and infrastructure. The company is likely to infuse Rs 1,000 crore in this venture.

A new research and development (R&D) centre is being set up at Patalganga in Navi Mumbai while its Vikhroli R&D unit in Mumbai is undergoing expansion.

The company is also setting up a factory to produce ‘bio-betters’ (biosimilars or reverse engineered versions of biotech drugs) in Goa. The first products will be launched in early 2012.

Cipla also plans to acquire Meditab Specialities for Rs 133.35 crore.

Meditab is expanding a bulk drug and intermediates business through its manufacturing facility in China. It also has a facility in Uganda and a strategic relationship for R&D of stem cell-based products, having facilities in India and Malaysia, through equity participation.

← All latest storiesBack to top →